Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

National Health Plan (NHP) 2021–2030 articulates a vision of “a healthy and prosperous nation where health and wellbeing are enjoyed by all,” anchored in evidence-based innovation as a fundamental ...

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...

As the global population ages, older adults with atherosclerotic cardiovascular disease (ASCVD) are projected to drive a ...

Men and partners are important contributors to the health of future generations, yet their own preconception health and wellbeing remain secondary considerations in research, practice, and policy.

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

In this large international cohort of immunocompromised patients with ARF, we identified key risk and protective factors for mortality and intubation. These findings could improve outcomes by ...

The care of immunocompromised adults with acute respiratory failure (ARF) remains one of the greatest challenges of intensive care medicine.1 Management of these patients is challenging because ...

Over the last three decades, critical care and emergency medicine have made great progress in recognising and managing sepsis through early recognition and protocolised resuscitation. For initial ...

Vertical health delivery programmes were highly effective in rapid roll-out of HIV services in high-burden countries in ...

Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true prevalence is difficult to determine ...